Legal & General Group PLC Merus N.V. Transaction History
Legal & General Group PLC
- $440 Billion
- Q2 2024
A detailed history of Legal & General Group PLC transactions in Merus N.V. stock. As of the latest transaction made, Legal & General Group PLC holds 41,391 shares of MRUS stock, worth $1.98 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,391
Previous 34,621
19.55%
Holding current value
$1.98 Million
Previous $1.56 Million
57.19%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding MRUS
# of Institutions
188Shares Held
59MCall Options Held
345KPut Options Held
222K-
Rtw Investments, LP New York, NY4.17MShares$199 Million4.12% of portfolio
-
Commodore Capital LP New York, NY3.2MShares$153 Million16.98% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.75MShares$131 Million3.41% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA2.4MShares$115 Million0.34% of portfolio
-
Samlyn Capital, LLC New York, NY2.32MShares$111 Million2.45% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.19B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...